Clinical Trial

tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment

Study acronym: LUMINA-brain
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this intervention is to investigate whether transcranial Direct Current Stimulation (tDCS) can alleviate Cancer-Related Cognitive Impairment (CRCI) in breast cancer survivors, as measured by changes in brain structures and cognitive performance. To assess the efficacy of tDCS, the investigators will compare outcomes between participants receiving active stimulation and those receiving sham stimulation (a placebo condition where participants believe they are receiving stimulation, but are not). Participants will: * Undergo a baseline MRI session * Receive either active or sham tDCS for six weeks * Undergo a follow-up MRI session * Complete cognitive tests and respond to psychosocial questionnaires before, during, and after the tDCS intervention
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-01.
Trial Details
NCT Number NCT07112521
Lead Sponsor University of Helsinki
Conditions Breast Cancer Survivor, Obesity, Overweight
Enrollment 40 participants
Start Date 2025-09-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-02